High-intensity interval training to improve fitness in brain tumor patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The FeelFit study evaluates the effectiveness of High-Intensity Interval Training (HIIT) in enhancing self-reported physical fitness among adult patients with primary brain tumors who have stable disease. Participants will be compared to a waiting-list control group to assess the impact of this exercise intervention. The study is part of the GRIP project, which focuses on improving the quality of life for brain tumor survivors. Secondary and exploratory outcomes will also be measured to provide a comprehensive understanding of the intervention's effects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* reduced self-reported physical fitness;
* minimum age of 18 years;
* diagnosed with a primary brain tumor;
* stable disease, i.e. no signs of radiological or clinical tumor progression;
* no oncological treatment for at least two months prior to inclusion;
* able to speak, read and write in Dutch.

Exclusion Criteria:

* Karnofsky Performance Score \< 70;
* already participated in a HIIT program \< 1 month prior;
* contraindication of exercise.

Where it's running

• VU University Medical Centers, location VUmc
  Amsterdam, Netherlands Recruiting

Study contacts

• Study coordinator: Marieke Blom, Msc
• Email: m.e.c.blom@amsterdamumc.nl
• Phone: +31 6 21522442

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Focused ultrasound to open the blood-brain barrier in adults with high-grade glioma on chemotherapy

  This trial tests whether focused ultrasound using the Next Generation Dome Helmet can safely open the blood-brain barrier in adults with glioblastoma who are receiving maintenance temozolomide chemotherapy.

  Recruiting Phase 1 Sunnybrook Health Sciences Centre · Toronto, Ontario · NCT07179328

• Investigating brain network changes in children with brain tumors after radiation therapy

  This study is trying to see how radiation therapy changes brain connections in children with brain tumors and how those changes might affect their thinking skills after treatment.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT06185686

• Characterizing immune cells in malignant brain tumors

  This study is trying to understand how immune cells behave in people with malignant brain tumors by looking at their blood and tumor samples before and after surgery.

  Recruiting IRCCS San Raffaele · Milan, Milan · NCT05831631

• Investigating the role of glutamate in glioblastoma

  This study is testing how levels of glutamate in blood and spinal fluid might affect the growth of glioblastoma in patients suspected of having this aggressive brain tumor.

  Recruiting IRCCS San Raffaele · Milan, Milan · NCT05775458

• Collection of blood samples from adults with brain tumors

  This study is collecting blood samples from adults with brain tumors to see if certain markers in the blood can help improve treatment outcomes after radiation therapy.

  Recruiting Duke University · Durham, North Carolina · NCT05480644

• Observing the growth of non-malignant brain tumors

  This study looks at how non-cancerous brain tumors grow over time in patients who don't have symptoms and aren't needing treatment, using regular MRI scans to track changes.

  Recruiting Seoul National University Hospital · Seoul · NCT05254197

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.